Glypican 2 As A Cancer Marker And Therapeutic Target
Technology
E-285-2016
Patent ID
E-285-2016-2-US-06
Country
US
Application Type
National Stage
Patent Status
Pending
Patent Number
Publication Number
US-2018-0318444
Application Number
15/773,256
IC
NCI
Date Filed
Date Issued
Patent PDF